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Abstract – Migration of activated neutrophils that have prolonged lifespan into inﬂamed organs is an
important component of host defense but also contributes to tissue damage and mortality. In this report, we
used biologically-inspired RGD-tagged rosette nanotubes (RNT) to inhibit neutrophil chemotaxis. We
hypothesize that RGD-RNT will block neutrophil migration through inhibition of MAPK. In this report,
RNT conjugated to lysine (K–RNT) and arginine-glycine-aspartic acid-serine-lysine (RGDSK-RNT) were
co-assembled in a molar ratio of 95/5. The effect of the resulting composite RNT (RGDSK/
K–RNT) on neutrophil chemotaxis, cell signaling and apoptosis was then investigated. Exposure to
RGDSK/K–RNT reduced bovine neutrophil migration when compared to the non-treated group
(p < 0.001). Similar effect was seen following treatment with ERK1/2 or p38 MAPK inhibitors.
Phosphorylation of the ERK1/2 and p38 MAPK was inhibited at 5 min by RGDSK/K–RNT (p < 0.05). The
RGDSD/K-RNT did not affect the migration of neutrophils pre-treated with avb3 integrin antibody
suggesting that both bind to the same receptor. RGDSK/K–RNT did not induce apoptosis in bovine
neutrophils, which was suppressed by pre-exposing them to LPS (p < 0.001). We conclude that RGDSK/K–
RNT inhibit phosphorylation of ERK1/2 and p38 MAPK and inhibit chemotaxis of bovine neutrophils.
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1. INTRODUCTION
Inﬂammation is a hallmark of many respira-
tory diseases of humans and animals. For exam-
ple, bovine respiratory disease (BRD) complex
is the most common and costly inﬂammatory
disease in feedlot cattle [26]. BRD complex
accounts for lower average daily gain, increased
cost of treatment and mortality [39]. Despite
advances in genetic selection, vaccination and
the use of antibiotics and anti-inﬂammatory
drugs to reduce inﬂammation, BRD remains a
major concern [26].
Activated neutrophils migrate into the lungs
to combat infections through production of var-
ious chemicals such as free oxygen species [1].
Neutrophil migration occurs through a series of
events that are regulated by chemoattractants
and adhesive proteins such as selectins and inte-
grins. Although the role of b2 integrins in neu-
trophil migration is well recognized, there is
some evidence that the avb3 integrin expressed
on neutrophils and endothelial cells may also
play a role in the movement of neutrophils
[4, 25]. Importantly, ligation of integrins
impacts cell migration through regulation of
the extracellular signal regulated protein kinase
(ERK) signaling [23, 48]. The ERK1/2 regu-
late cell motility through phosphorylation of
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kinase, cytoskeletal proteins, and Ca
2+-activated
proteolytic enzymes. In addition, active ERK1
in association with avb3 integrin is essential
for effective functions of this integrin during
cell movement and spreading on vitronectin
[36]. Currently, there are no data on the role
of MAPK cell signaling or the avb3 integrin
in the migration of bovine neutrophils.
Neutrophilsaretheﬁrstlineofdefenseagainst
bacterial infections and are needed for elimina-
tionofinfections.However,intensiveandexces-
sive sequestration of activated neutrophils in the
lungscanexacerbatetheinﬂammatorycondition
[1]. Furthermore, activation of neutrophils
suppresses their constitutive apoptosis, which
delaystheirdeathandclearancebymacrophages
leading to increased tissue damage [28, 47].
Because the tissue damage caused by the acti-
vated neutrophils in lung is associated with
increased morbidity and mortality, we need to
understand mechanisms to control migration
andlifespanofneutrophilsinlunginﬂammation.
Nanotechnology enables us to develop and
exploit the novel properties of materials at the
nanometer scale [31], a scale at which most liv-
ing systems operate. The rosette nanotubes
(RNT) are a new class of biologically-inspired
nanotubes which are self-assembled in water
from low molecular weight synthetic organic
modules[12,13].TheformationofRNTischar-
acterizedbytheself-assemblyoftheG^Cmotif,
which mimics the complementary hydrogen
bonding arrays of DNA bases guanine and cyto-
sine. G^C self-assembles under physiological
conditions into a six-membered supermacrocy-
cle (called rosette) held together by 18 H-bonds,
which in turn self-organizes into a helical
stack with an outer diameter of 3.5 nm (for
K–RNT), a 1.1 nm channel and up to several
lm in length [10, 12, 14]. Functional groups
covalently attached to the G^C motif are
expressed on the RNTsurface and impart phys-
ical and chemical properties suitable for many
applications [45]. The stability of the RNT
depends on several factors including density of
functional groups, electrostatics (net charge),
hydrophobic and stacking interactions, as well
aspHandtemperature[12].Wehaveshownthat
RGDSK/K-RNT do not induce inﬂammation
invivoorcauseoveractivationoflungepithelial
and macrophage cells lines in vitro [20–22].
More recently, we have shown that RGDSK/
K-RNTactivate p38 MAPK cell signaling path-
ways leadingtoinductionofapoptosisinhuman
bronchiolar adenocarcinoma cell line [41].
In this report, RNT conjugated to a lysine
amino acid (K–RNT) and RNT conjugated
to arginine-glycine-aspartic acid-serine-lysine
(RGDSK-RNT) were co-assembled in a ratio of
95/5. The effects of the composite RNT
(RGDSK/K–RNT) on bovine neutrophil chemo-
taxis, cell signaling and apoptosis were then
investigated in vitro. The data show that
RGDSK/K–RNT inhibit MAPK cell signal-
ing and chemotaxis, most probably via the inte-
grin avb3, without inducing apoptosis in
neutrophils.
2. MATERIALS AND METHODS
2.1. Isolation of bovine blood neutrophils
Blood from healthy adult (3–4 years old), non-
pregnant cattle that were without any clinical signs
of disease and with normal hemograms was collected
from the jugular vein with prior approval of the Uni-
versity of Saskatchewan’s Animal Research Ethics
Board. The blood (20 mL/animal) collected from
individual animals was not pooled. Neutrophils were
isolated by density gradient centrifugation with lym-
phocyte separation media (LSM, MP Biomedicals,
Solon, USA) after using ammonium chloride for
erythrocyte lysis [37]. After isolation, neutrophils
were suspended in RPMI-1640 medium (Invitrogen,
Carlsbad, USA) modiﬁed with 10% fetal bovine
serum and glutamine. The viability of isolated
PMN was assessed immediately by trypan blue
(Sigma-Aldrich, St. Louis, USA) exclusion. Cell
cytospin preparation stained with Diff-Quik (EMD
Chemicals, Gibbstown, USA) was used for differen-
tial cell count. PMN viability was greater than 97%
and their purity was more than 90%.
2.2. Neutrophil chemotaxis
2.2.1. Neutrophil chemotaxis assay
Chemotaxis of bovine neutrophils was assessed
in 48-well Boyden chambers as described previ-
ously [11]. Brieﬂy, neutrophil suspensions (50 lL)
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wells of the chamber in triplicate for each treat-
ment with 5 · 10
4 cells per well. Isolated neutro-
phils were exposed to RGDSK/K–RNT ((RGD–
RNT) = 0.1 lM, (K–RNT) = 2 lM; Fig. 1)a n d
collected at 0, 5, 10, 15, 30 and 60 min. Cells in
upper wells were allowed to migrate toward chemo-
attractant fMLP in lower wells (114 nM) at 37  C
in humidiﬁed air with 5% CO2 for 30 min. After
wiping the non-migrated cells off, the ﬁlters were
dried and stained with Diff-Quik (EMD Chemicals,
Gibbstown, USA). The stained ﬁlter was mounted
on glass slides and the cells within the ﬁlter pores
were then counted in 5 random ﬁelds under light
microscopy at 400· magniﬁcation. The results are
presented as the number of migrated neutrophils
per microscopic ﬁeld.
2.2.2. Blocking the avb3 integrin by antibody
Isolated bovine neutrophils were suspended in
modiﬁed RPMI-1640 medium, resting for 1 h before
any treatments. Neutrophils were incubated with the
anti-human avb3 monoclonal antibody or isotype-
matched antibody (R&D Systems, Minneapolis,
USA) at the concentration of 1 lg/mL for 1 h at
room temperature [2, 18]. The cells were then used
for chemotaxis assay.
2.2.3. Blocking MAPK by MAPK inhibitors
Isolated bovine neutrophils were incubated with
20 lM of each MAPK inhibitors, either ERK1/2
inhibitor UO126 (Cell Signaling Technology, Dan-
vers, USA) or p38 MAPK inhibitor SB239063 (Cal-
biochem, Temecula, USA), for 1 h at 37  Ci n
humidiﬁed air with 5% CO2. As UO126 and
SB239063 were dissolved in DMSO (dimethyl sulf-
oxide), DMSO was used as a negative control. The
concentration of DMSO in all treatments was 0.2%
(v/v) [17]. These cells were used for chemotaxis
assay.
2.3. Enzyme linked-immunosorbent assay
(ELISA) for MAPK phosphorylation
Isolated neutrophils were exposed to RGDSK/K–
RNT and collected at 0, 5, 10, 15, 30 and 60 min.
fMLP (5 lM) was also used as a positive control
to induce phosphorylation of MAPK for 1 min at
37  C[ 9]. Stimulation was stopped by cell sedimen-
tation and discarding of supernatants followed by
freezing pellets in liquid nitrogen. Subsequently, cell
pellets were stored at  80  C for later use. Cellular
extracts were prepared by solubilizing pelleted cells
at 5 · 10
6 cells/mL in lysis buffer comprised of
EDTA (1 mM), Triton X-100 (0.5%), NaF (5 mM),
urea (6 M), leupeptin (10 lg/mL), pepstatin (10 lg/
mL), PMSF (100 lM), aprotinin (3 lg/mL), sodium
pyrophosphate (2.5 mM) and activated sodium
orthovanadate (1 mM) in PBS, pH 7.2–7.4. After
vortex and ice incubation, supernatants were col-
lected. Sample protein concentration was quantiﬁed
using a protein microassay based on the Bradford
dye-binding procedure (Bio-Rad, Mississauga,
Canada). Cell lysates in duplicate for each time points
were then used for sandwich ELISA (DuoSet
  IC kit,
R&D Systems, Minneapolis, USA) to measure phos-
phorylated levels of ERK1/2 and p38 MAPK.
Results are expressed by the amount of phosphory-
lated ERK1/2 or p38 MAPK (ng) per lgo ft o t a l
protein quantiﬁed.
Figure 1. Model of the RNT investigated in this study. (A color version of this ﬁgure is available
at www.vetres.org.)
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2.4.1. Cell treatments
Isolated neutrophils at 5 · 10
6 cells/mL were
pre-incubated at 37  C in humidiﬁed air with
5% CO2 with or without LPS (lipopolysaccharide,
1 lg/mL). After 30 min, LPS was discarded and
cells were resuspended in modiﬁed RPMI-1640.
Cells were then treated with 0.1 lM of RGDSK
peptide (an Arg-Gly-Asp-Ser-Lys containing peptide,





90–RNT (RGDSK–RNT) = 0.2 lM,
(K–RNT) = 2 lM) or modiﬁed RPMI-1640 only
for 18, 24 and 36 h at 37  C in humidiﬁed air with
5% CO2. Cells were centrifuged at 400 g followed
by the removal of supernatant, snap-freezing and
storage at  80  C.
2.4.2. Caspase-3 quantiﬁcation
Cell pellets were applied for quantitative determi-
nation of caspase-3 using caspase-3 colorimetric
assay kit (Assay Designs, Inc., Ann Arbor, USA).
Cell lysates were used for caspase-3 colorimetric
detection. The conversion was then measured kineti-
cally at 405 nm. The activity of caspase-3 in samples
was calculated as unit/mL.
2.4.3. Flow cytometry
For ﬂow cytometry, the Annexin V-FITC apopto-
sis detection kit II from BD Biosciences, Mississau-
ga, Canada [46]. Brieﬂy, the cells were suspended
in 100 lLo f1 · Annexin V binding buffer at the
concentration of 1 · 10
6 cells/mL followed by addi-
tion of 5 lL of Annexin V-FITC and 5 lLo fp r o p i -
dium iodide, and incubation for 15 min at room
temperature in the dark. Finally, 400 lLo f1 ·
Annexin V binding buffer was added. Cells were
analyzed with ﬂow cytometer and the results were
expressed as percentages.
2.5. Data analysis
Data was analyzed using SigmaStat
  statistical
software. All-pairwise comparisons were performed
followed by analysis of variance to compare differ-
ences between treatment groups. Results of at least
three separate experiments are displayed as mean ±
standard error of the mean (SEM). Differences are
considered statistically signiﬁcant when the probabil-
ity (p) < 0.05.
3. RESULTS
3.1. Effect of RGD-RNT on neutrophil
chemotaxis
Control neutrophils exposed to RGDSK/
K–RNTshowed reduced migration compared to
the non-treated group (p < 0.01, Fig. 2). Neutro-
phil migration towards fMLP was also inhibited
by RGDSK/K–RNT at 5 min compared to the
control.
3.2. Effect of RGD-RNT on MAPK
phosphorylation
To understand the molecular effects of
RGD-RNT on neutrophil migration, cells were
exposed to RGDSK/K–RNT with or without
fMLP followed by quantiﬁcation of the phos-
phorylated ERK1/2 and p38 MAPK. Neutro-
phils exposed to fMLP showed signiﬁcant
increase in phosophorylation of ERK1/2
(Fig. 3A)a n dp 3 8( Fig. 3B) at 5 min of the
exposure. There was a difference between treat-
ment groups for ERK1/2 (p < 0.001, Fig. 3C)
and p38 MAPK (p < 0.01, Fig. 3D). The phos-
phorylation of both the ERK1/2 and p38 was
inhibited at 5 min (p < 0.05) of exposure to
RGDSK/K–RNT followed by an increase at
10 min, which was sustained until 60 min.
Figure 2. Effect of RGDSK/K–RNTon bovine neu-
trophilchemotaxis.WhilefMLPsigniﬁcantlyincreased
the migration of neutrophils, exposure to RGDSK/
K–RNT for 5 min, inhibited migration of control or
fMLP-exposed neutrophils. Results are mean ± SEM
of three separate experiments. Different letters above
barsindicate signiﬁcantdifferences (p < 0.01).
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inhibitor (UO126) or p38 inhibitor
(SB239063) signiﬁcantly reduced (p <0 . 0 0 1 )
their migration in response to fMLP (Fig. 4).
The inhibitory effects of RGDSK/K–RNT and
MAPK inhibitors on neutrophil chemotaxis
were not statistically different (Fig. 4).
3.3. Involvement of the avb3 integrin on bovine
neutrophil chemotaxis
We treated neutrophils with a monoclonal
antibody against the avb3 integrin to deter-







































Figure 4. Inhibition of bovine neutrophil chemo-
taxis induced by RGDSK/K–RNT or MAPK inhib-
itors. Neutrophil migration, determined by counting
the number of neutrophils stuck in ﬁlter pores after
30 min of chemotaxis assay, was signiﬁcantly
diminished after exposure to RGDSK/K–RNT for
5 min or MAPK inhibitors for 1 h. Modiﬁed RPMI-
1640 and fMLP (114 nM) in the lower chamber
were used as negative and positive controls,
respectively. DMSO (dimethyl sulfoxide), a solvent
of MAPK inhibitors, was used as a negative control.
Results of three independent experiments are
displayed as mean ± SEM. Signiﬁcant differences
between treatment groups are expressed by different
letters above bars (p < 0.001).












































































































Figure 3. Phosphorylation of ERK1/2 (A, C)
and P38 (B, D) MAPK in bovine neutrophils.
fMLP induced signiﬁcant phosophorylation of
ERK1/2 (A) and P38 (B) MAPK within 5 min of
exposure. RGDSK/K RNT signiﬁcantly suppressed
phosophorylation of ERK1/2 (C) and p38 (D)
MPAK within 5 min of treatment. The phosphor-
ylation of ERK1/2 (C) and p38 (MAPK) returned to
control values at 10 min and remained so till
60 min. Results of three independent experiments
are represented as mean ± SEM. Signiﬁcant differ-
ences between treatment groups are expressed by
different letters above bars (p < 0.001 and p < 0.01
for ERK and P38, respectively).
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the fMLP-induced migration of neutrophils
pre-incubated with the integrin antibody. The
isotype-matched antibody or the avb3 integrin
antibody alone did not affect fMLP-induced
neutrophil migration (p < 0.001, Fig. 5).
3.4. Effects of RGD-RNT on bovine neutrophil
apoptosis
Neutrophils were incubated without (con-





90–RNT for 0, 18, 24
and 36 h. As shown in Figure 6, caspase-3
activity was increased over time in LPS-stimu-
lated and non-stimulated neutrophils. However,
the activity was not different at 18, 24 and 36 h
of treatment with the same agent. The RGDSK
peptide and RGDSK/K-RNT did not induce an
increase in caspase-3 activity, except for the sig-
niﬁcant induction of caspase-3 activity by
RGDSK
10/K
90–RNT compared to the control
at 18 h (p < 0.05). In addition, LPS caused sig-
niﬁcant suppression of caspase-3 activity in all
treatments at all time points (p < 0.001). There
was no effect on neutrophil apoptosis at 24 h of
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tosis was markedly suppressed in cells treated
with LPS for 30 min (p < 0.001, Fig. 7).
4. DISCUSSION
Neutrophil migration into sites of infections
is a critical component of the host response
[33]. However, there is growing evidence that
dysregulated migration of activated neutrophils
leads to tissue damage which results in morbid-
ity and mortality [35]. This creates a need to
develop approaches to ﬁne-tune their migration
into inﬂamed organs such as the lungs in BRD
in cattle. Here we show that RGDSK/K–RNT
inhibit fMLP-induced chemotaxis of neutro-
phils and MAPK signaling without affecting
their apoptosis.
4.1. RGDSK/K–RNT suppress MAPK
phosphorylation and neutrophil chemotaxis
Our data show that RGDSK/K–RNT inhibit
neutrophil chemotaxis in response to fMLP.
The role of signaling molecules such as MAPK
and ERK1/2 in cell migration is well estab-
lished [19]. We observed increased phosoph-
orylation of MAPK and ERK1/2 in the
neutrophils exposed to the fMLP. However,
treatment of neutrophils with RGD-RNTcaused
signiﬁcant suppression of ERK1/2 and p38
MAPK activation. Integrin engagement of
RGD-ligand induces various intracellular sig-
nals including MAPK pathways that regulate





































bovine neutrophil chemotaxis. Compared to the
control, neutrophil migration was signiﬁcantly
higher in fMLP alone or with isotype-matched
antibody or the avb3 integrin antibody but was not
different among the three fMLP treatments. While
RGDSK/K–RNT alone signiﬁcantly reduced the
fMLP-induced migration, the effect was not noticed
in neutrophils pretreated with the avb3 integrin
mAb. Modiﬁed RPMI-1640 and fMLP (114 nM) in
the lower chamber were used as negative and
positive controls, respectively. Results of three
independent experiments are displayed as mean-
± SEM. Signiﬁcant differences between treatment
groups are expressed by different letters above bars
(p < 0.001).
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important for focal adhesion disassembly and
direct phosphorylation of myosin light chain
kinase that lead to cell migration [24, 34]. Even
though ERK enables direct and rapid regulation
of cytoskeletal dynamics in migrating cells, the
integrin ligation is required for induction and
persistence of cell migration with regard to
MAPK regulation [23, 34, 40, 48]. The impact
of MAPK and ERK1/2 suppression mediated
by RGD-RNT in neutrophil migration is further
supported by the fact that chemical inhibitors of
p38 MAPK and ERK1/2 and the RGDSK/K–
RNT were equally potent in inhibiting neutro-
phil chemotaxis. Therefore, RGDSK/K–RNT
may inhibit neutrophil chemotaxis through inhi-
bition of p38 MAPK and ERK1/2.
Neutrophil motility is governed by integrin
signaling [23] including that by integrin avb3
[25, 30]. Integrins binding to RGD motif
changes the conformation that in turn regulates
integrin afﬁnity to ligands and integrin redistri-
bution on the cell membrane [7, 43]. The poten-
tial advantage of RGDSK/K–RNT compared to
cyclic RGD peptides to modulate neutrophil
migration is that the nanotubes may be highly
effective at lower concentrations owing to their
multivalent interactions with the integrins on
the neutrophil surface as has been shown
recently [29]. RGDSK/K–RNT had no effect
on neutrophils pre-treated with anti–avb3 anti-
body. It appears, therefore, that both the anti-
body and the RGDSK/K–RNT bind to the
same protein, the avb3 integrin. The inhibition
of human neutrophil migration has been
observed when neutrophils were treated with
ﬂavoridin (FL), an RGD-disintegrin ligand of
avb3a n da5b1[ 3, 30]. Intriguingly, the
fMLP-induced neutrophil migration was not
affected by the integrin avb3 antibody or
the isotype-matched antibody alone. We do
not know the precise reasons for these
Figure 6. Effect of RGDSK/K–RNT on caspase-3 activity. Neutrophils with or without pre-exposure to




90–RNT for 0, 18, 24 and
36 h. Cell lysates were used for measurement of caspase-3 activity. Results of three different experiments
are displayed as mean ± SEM. p < 0.001 when compared LPS and non-LPS treated groups.
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to conformational changes in the integrin
expressed on the neutrophil surface or endocy-
tosis of the antibody-receptor complex to elim-
inate physical effects of the ligation [16, 44].
We believe that there is a need for additional
experiments to clarify the role of the integrin
in bovine neutrophil migration. Nevertheless,
the data show that RGDSK/K–RNT inhibit
neutrophil chemotaxis by suppressing phosoph-
orylation of ERK1/2 and p38 and through inhi-
bition of the avb3i n t e g r i n .
4.2. Effect of RGDSK/K–RNT on apoptosis
of bovine neutrophils
The activation of neutrophils extends their
lifespan by inhibiting constitutive apoptosis
in neutrophils and the prolonged lifespan of
activated neutrophils is believed to cause
excessive tissue damage [27]. There is a con-
certed research effort underway to modulate
the lifespan of activated neutrophils. We deter-
mined the effect of RGDSK/K–RNT on the
neutrophil lifespan by measuring caspase-3
Figure 7. The effect of LPS on bovine neutrophil apoptosis at 24 h in the presence of RGDSK
5/K
95–RNT.
The percentage of neutrophil apoptosis is displayed as mean ± SEM of 5 separate experiments (A). The
level of apoptosis was measured by Annexin V-FITC staining after 24 h incubation without LPS-
pretreatment (B) and with LPS-pretreatment (C). Signiﬁcant differences between treatment groups are
expressed by different letters above bars.
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of the critical enzymes involved in the termi-
nal events leading to apoptosis. Activation of
caspase-3 is induced rapidly in apoptotic gran-
ulocytes without early mitochondrial changes
[32]. Cyclic RGD peptide upon internalization
by the cells binds to RGD-binding motif on
procaspase-3 to induce its activation [6, 8].
While treatment of bovine neutrophils with
LPS for 30 min signiﬁcantly suppressed cas-
pase-3 activity, treatment with RGDSK
10/
K
90–RNT did not induce the activity of cas-
pase-3 except at 18 h. We further assessed
neutrophil apoptosis at 24 h with ﬂow cyto-
metric method using Annexin V and propidi-
um iodide (PI) labeled with ﬂourescein
isothiocyanate (FITC) [46]. Although as
expected LPS treatment signiﬁcantly inhibited
apoptosis in neutrophils [5, 38, 42], there
was no effect of RGDSK peptide, RGDSK
5/
K
95 RNT or RGDSK
10/K
90–RNT on neutro-
phil apoptosis compared to the control. These
data are in contrast to our recent observations
on the induction of apoptosis by similar RNT
in a human adenocarcinoma cell line [41]. One
of the reasons could be that while neutrophil is
a terminally differentiated cell, the adenocarci-
noma cell line is a dividing cell line which
may create differences in the actions of
RGDSK/K–RNT. Second, considering that
the RNT increased caspase-3 expression at
18 h of the treatment, it is possible that a
higher concentration of the RNT or higher pro-
portion of K-RNT in the combination or pro-
longed treatment with it may be needed to
induce caspase-3 activity and apoptosis in acti-
vated neutrophils.
This study provides the ﬁrst evidence that
RGDSK/K–RNT inhibit phosphorylation of
the ERK1/2 and p38 MAPK and chemotaxis
of bovine neutrophils. These bovine phos-
phorylated proteins, ERK1/2 and p38 MAPK,
were quantiﬁed for the ﬁrst time by capture
ELISA. The data also allude to a complex
role of the avb3i n t e g r i ni nb o v i n en e u t r o p h i l
migration and need for additional experi-
ments. Lastly, RGDSK/K–RNT at the concen-
trations used in our studies did not induce
apoptosis in LPS-treated bovine neutrophils.
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